Clinical Trials Browser

Neoplasm Metastasis × Etoposide × Breast × Clear all

NCT00810017 2022-05-19

Phase 2 Study of Trastuzumab and Etoposide for Her2 Positive Breast Cancer

Phase 2 Terminated

2 enrolled 3 charts

Breast Neoplasms, Neoplasm Metastasis

NCT01492556 2013-03-15

Study of Etoposide in Treating Patients With Recurrent or Metastatic Breast Cancer

Phase 2 Unknown

Breast Neoplasms, Neoplasm Metastasis, Recurrence